AR064262A1 - Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato - Google Patents
Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonatoInfo
- Publication number
- AR064262A1 AR064262A1 ARP070105120A ARP070105120A AR064262A1 AR 064262 A1 AR064262 A1 AR 064262A1 AR P070105120 A ARP070105120 A AR P070105120A AR P070105120 A ARP070105120 A AR P070105120A AR 064262 A1 AR064262 A1 AR 064262A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally
- liquid pharmaceutical
- amount
- therapeutic use
- bisphosphonate
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 239000002131 composite material Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 4
- 229940122361 Bisphosphonate Drugs 0.000 abstract 3
- 150000004663 bisphosphonates Chemical class 0.000 abstract 3
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 238000011200 topical administration Methods 0.000 abstract 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 2
- 235000011187 glycerol Nutrition 0.000 abstract 2
- 239000008240 homogeneous mixture Substances 0.000 abstract 2
- 239000003906 humectant Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- -1 bisphosphonate compound Chemical class 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 239000002085 irritant Substances 0.000 abstract 1
- 231100000021 irritant Toxicity 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000344 non-irritating Toxicity 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86630606P | 2006-11-17 | 2006-11-17 | |
| US86629406P | 2006-11-17 | 2006-11-17 | |
| EP06291786A EP1923050A1 (en) | 2006-11-17 | 2006-11-17 | Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| EP06291785A EP1923049A1 (en) | 2006-11-17 | 2006-11-17 | Pharmaceutical compositions comprising a bisphosphonate compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR064262A1 true AR064262A1 (es) | 2009-03-25 |
Family
ID=38895592
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070105120A AR064262A1 (es) | 2006-11-17 | 2007-11-16 | Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato |
| ARP070105121A AR064263A1 (es) | 2006-11-17 | 2007-11-16 | Composiciones farmaceuticas que comprenden un compuesto bisfosfato |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070105121A AR064263A1 (es) | 2006-11-17 | 2007-11-16 | Composiciones farmaceuticas que comprenden un compuesto bisfosfato |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20080182822A1 (OSRAM) |
| EP (2) | EP2088996A1 (OSRAM) |
| JP (2) | JP2010510195A (OSRAM) |
| AR (2) | AR064262A1 (OSRAM) |
| AU (2) | AU2007321108A1 (OSRAM) |
| CA (2) | CA2669488A1 (OSRAM) |
| IL (2) | IL198678A0 (OSRAM) |
| TW (2) | TW200829282A (OSRAM) |
| WO (2) | WO2008059059A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080182822A1 (en) * | 2006-11-17 | 2008-07-31 | Besins Healthcare Sa | Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound |
| EP2147674A1 (en) * | 2008-07-24 | 2010-01-27 | Besins Healthcare | Transdermal pharmaceutical compositions comprising danazol |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| PT2459176T (pt) | 2009-07-31 | 2017-12-11 | Gruenenthal Gmbh | Método de cristalização e biodisponibilidade |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
| US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
| WO2019232114A1 (en) * | 2018-06-01 | 2019-12-05 | The University Of North Carolina At Chapel Hill | Injectable thermoresponsive hydrogels as a combinatory modality for controlled drug delivery, biomaterial implant and 3d printing bioink |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX21452A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| MX21453A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| GB9408775D0 (en) * | 1994-05-04 | 1994-06-22 | Ciba Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration |
| JP3411690B2 (ja) * | 1994-09-21 | 2003-06-03 | 帝人株式会社 | 局所投与用アレンドロン酸ナトリウム製剤 |
| US6905701B2 (en) * | 1997-06-11 | 2005-06-14 | Umd, Inc. | Formulations for transmucosal vaginal delivery of bisphosphonates |
| US6416737B1 (en) * | 1998-11-19 | 2002-07-09 | Board Of Trustees Of The University Of Arkansas | Increasing bone strength with selected bisphosphonates |
| US20050074487A1 (en) * | 1999-12-16 | 2005-04-07 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
| JP2001253827A (ja) * | 2000-02-15 | 2001-09-18 | Pfizer Prod Inc | 骨粗鬆症を治療するための組成物および方法 |
| AU778431B2 (en) * | 2000-05-05 | 2004-12-02 | F. Hoffmann-La Roche Ag | Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| WO2003068241A1 (fr) * | 2002-02-14 | 2003-08-21 | Yamanouchi Pharmaceutical Co., Ltd. | Preparations percutanees |
| JP4394888B2 (ja) * | 2002-02-14 | 2010-01-06 | 救急薬品工業株式会社 | 経皮投与製剤 |
| US20070287688A1 (en) * | 2003-07-11 | 2007-12-13 | Macro Chem Corporation | Pharmaceutical Compositions for Topical Application |
| US20050119230A1 (en) * | 2003-09-18 | 2005-06-02 | Alexandra Glausch | Pharmaceutical products comprising bisphosphonated |
| MY141763A (en) * | 2003-09-18 | 2010-06-30 | Novartis Ag | Pharmaceutical products comprising bisphosphonates |
| JP2007510628A (ja) * | 2003-10-14 | 2007-04-26 | ダーマトレンズ，インコーポレイティド | 親水性薬剤の経皮投与の促進 |
| US20080182822A1 (en) * | 2006-11-17 | 2008-07-31 | Besins Healthcare Sa | Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound |
-
2007
- 2007-11-16 US US11/941,393 patent/US20080182822A1/en not_active Abandoned
- 2007-11-16 EP EP07847196A patent/EP2088996A1/en not_active Withdrawn
- 2007-11-16 AR ARP070105120A patent/AR064262A1/es unknown
- 2007-11-16 JP JP2009536746A patent/JP2010510195A/ja active Pending
- 2007-11-16 CA CA002669488A patent/CA2669488A1/en not_active Abandoned
- 2007-11-16 AU AU2007321108A patent/AU2007321108A1/en not_active Abandoned
- 2007-11-16 US US11/941,417 patent/US20080167271A1/en not_active Abandoned
- 2007-11-16 AU AU2007321109A patent/AU2007321109A1/en not_active Abandoned
- 2007-11-16 CA CA002669489A patent/CA2669489A1/en not_active Abandoned
- 2007-11-16 WO PCT/EP2007/062472 patent/WO2008059059A1/en not_active Ceased
- 2007-11-16 AR ARP070105121A patent/AR064263A1/es unknown
- 2007-11-16 JP JP2009536745A patent/JP2010510194A/ja active Pending
- 2007-11-16 WO PCT/EP2007/062473 patent/WO2008059060A1/en not_active Ceased
- 2007-11-16 EP EP07847195A patent/EP2114368A1/en not_active Withdrawn
- 2007-11-19 TW TW096143765A patent/TW200829282A/zh unknown
- 2007-11-19 TW TW096143764A patent/TW200831130A/zh unknown
-
2009
- 2009-05-11 IL IL198678A patent/IL198678A0/en unknown
- 2009-05-12 IL IL198698A patent/IL198698A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007321109A1 (en) | 2008-05-22 |
| WO2008059059A1 (en) | 2008-05-22 |
| WO2008059060A1 (en) | 2008-05-22 |
| US20080182822A1 (en) | 2008-07-31 |
| AU2007321108A1 (en) | 2008-05-22 |
| CA2669489A1 (en) | 2008-05-22 |
| AR064263A1 (es) | 2009-03-25 |
| IL198678A0 (en) | 2010-02-17 |
| TW200831130A (en) | 2008-08-01 |
| AU2007321109A2 (en) | 2009-06-11 |
| EP2088996A1 (en) | 2009-08-19 |
| CA2669488A1 (en) | 2008-05-22 |
| IL198698A0 (en) | 2010-02-17 |
| US20080167271A1 (en) | 2008-07-10 |
| EP2114368A1 (en) | 2009-11-11 |
| JP2010510195A (ja) | 2010-04-02 |
| TW200829282A (en) | 2008-07-16 |
| JP2010510194A (ja) | 2010-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR064262A1 (es) | Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato | |
| JP5731446B2 (ja) | 局所用生体付着性製剤 | |
| AR063201A1 (es) | Composiciones farmaceuticas de ropinirol y metodos de uso de las mismas | |
| CA2594710C (en) | Topical bioadhesive formulations | |
| BRPI0822162B8 (pt) | composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal | |
| BRPI0509708A (pt) | composição de espuma de pimecrolimus contendo glicol de hexileno, opcionalmente álcool de oleil, dimetilisosorbìdeo e/ou triglicerìdeos de cadeia média | |
| SG156624A1 (en) | Organo-gel formulations for therapeutic applications | |
| CL2013003163A1 (es) | Composición transdermica de ibuprofeno, util en el tratamiento del dolor o la inflamacion. | |
| EA200601253A1 (ru) | Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения | |
| CL2009002183A1 (es) | Uso de una composicion topica que comprende 2.5% de imiquimod y un vehiculo farmaceuticamente aceptable para preparar un medicamento util para tratar queratosisi actinica; composicion topica. | |
| BRPI0416260A (pt) | método para tratar, prevenir ou controlar uma doença ou distúrbio relacionada com amianto, e, composição farmacêutica | |
| UY29377A1 (es) | Nuevas formilaciones líquidas de rotavirus, su preparación y sus usos. | |
| AR055552A1 (es) | Preparacion topica refrescante para parches y metodos para utilizar la misma | |
| JP2016510807A5 (OSRAM) | ||
| PE20080523A1 (es) | Composiciones farmaceuticas topicas que comprenden un modificador de respuesta inmune | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| JP2006502166A5 (OSRAM) | ||
| AR069572A1 (es) | Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal | |
| CL2004000899A1 (es) | Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion. | |
| ITMI932634A1 (it) | Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico | |
| CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
| PE20040548A1 (es) | Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2 | |
| CN1503655A (zh) | 糖摄取促进剂 | |
| AR064185A1 (es) | Composiciones y metodos para tratar las convulsiones | |
| ES2732892T3 (es) | Composición de tratamiento de hongos en las uñas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |